SCHEMBL29795606

SCHEMBL29795606

CC(C)(C)OC(=O)N1CC2CCC(C1)N2c1cccc(N)c1N

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
GPR119 Q8TDV5 3/20 0.42
USP30 Q70CQ3 3/20 0.40
KDM1A O60341 2/20 0.40
HDAC1 Q13547 2/20 0.39
EGFR P00533 2/20 0.39
SRC P12931 2/20 0.39
NAMPT P43490 1/20 0.39
CTSD P07339 1/20 0.39
CTSE P14091 1/20 0.39
BACE1 P56817 1/20 0.39
HDAC2 Q92769 1/20 0.39
ABL1 P00519 1/20 0.38
ABL2 P42684 1/20 0.38
RORC P51449 1/20 0.38
SMARCA2 P51531 1/20 0.38
SMARCA4 P51532 1/20 0.38
PBRM1 Q86U86 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123370 1.00 SCN9A (0.43) SCN9AGPR119USP30KDM1AHDAC1
SCHEMBL29795605 1.00 SCN9A (0.43) SCN9AGPR119USP30KDM1AHDAC1
SCHEMBL29745148 0.84 GPR119 (0.41) SCN9AGPR119USP30HDAC1EGFR
SCHEMBL23122914 0.84 GPR119 (0.41) SCN9AGPR119USP30HDAC1EGFR
SCHEMBL29795670 0.81 HDAC1 (0.46) GPR119USP30KDM1AHDAC1NAMPT
SCHEMBL23124336 0.81 HDAC1 (0.46) GPR119USP30KDM1AHDAC1NAMPT
SCHEMBL31152780 0.78 SMARCA2 (0.55) GPR119NAMPTBACE1SMARCA2SMARCA4
SCHEMBL1249642 0.78 SMARCA2 (0.55) GPR119NAMPTBACE1SMARCA2SMARCA4
SCHEMBL30796382 0.78 USP30 (0.49) SCN9AGPR119USP30EGFRSRC
SCHEMBL20156957 0.77 GPR119 (0.47) SCN9AGPR119USP30NAMPTRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031532-A1 SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed